CIMIT’s CINTA and NeuroTech Harbor, through the NIH Blueprint MedTech program, have started accepting pre-proposals from academic and industry applicants who have emerging technologies that aim to improve the prevention, diagnosis, and/or treatment of disorders involving the nervous system or consequences of such a disease or injury.

Awards up to $500K will be made available to the most promising and innovative neurotechnologies to help accelerate their development toward commercialization.

A major emphasis of this program is to create opportunities for diverse innovators, including those who have been traditionally underrepresented in the neurotech space.

Program Details:

• Awards up to $500K to help support development toward commercialization
• Mentorship from experienced medtech commercialization experts
• Support to address business, regulatory, clinical, and technical project areas

The deadline for this opportunity has passed.